Searching... Searching...
  • NVP + NA
  • Köp NA
  • Sälj NA
  • Senast NA
  • SEK

  • NEVPF +NA
  • Buy NA
  • Sell NA
  • Latest NA
  • USD

Developing Therapies for Primary Mitochondrial Diseases: Bridging the Gaps

NeuroVive will attend the workshop Developing Therapies for Primary Mitochondrial Diseases: Bridging the Gaps, at the US FDA in Silver Spring, Washington DC, on 6 September 2019.

NeuroVive's team consists of Chief Medical Officer & VP Preclinical and Clinical Development, Magnus Hansson, and Director Clinical & Regulatory Affairs, Matilda Hugerth.

"Given the complexities of primary mitochondrial diseases and, by extension, the challenges of designing informative clinical trials in this group of rare diseases, this scientific symposium will bring together academic physicians, FDA regulatory experts, and experts from related disciplines to exchange ideas on ways to address the challenges and to promote drug development in this challenging field."

– https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/developing-therapies-primary-mitochondrial-diseases-bridging-gaps-09062019-09062019